Who owns Vertex Pharmaceuticals (VRTX)? Superinvestor holders
5 superinvestors of the 157 tracked here hold Vertex Pharmaceuticals (VRTX) in their latest 13F filing, with $846.3M between them. Tweedy, Browne team gives it the most weight: 1.11% of the reported portfolio. In their latest reported quarter, Jim Simons (1938–2024), Israel Englander and Ken Griffin added; Tweedy, Browne team and Baillie Gifford team reduced.
Key facts
- Superinvestors holding it
- 5 of 157
- Biggest holder
- Ken Griffin, $253.5M
- Largest weight
- Tweedy, Browne team, 1.11%of their portfolio
- Combined value
- $846.3M
- Bought last quarter
- 3
- Sold last quarter
- 2
From each investor's latest 13F filing: 92 investors report Q3 2026, 65 investors report Q2 2026. Latest filing in this set: Nov 16, 2026.
| # | Investor | Share of their portfolio | Value | Shares | Last quarter | Shares moved | Quarter |
|---|---|---|---|---|---|---|---|
| 1 | Tweedy, Browne teamTweedy, Browne Company | 1.11% | $13.6M | 26.01K | ▼ Reduced 35% | −14.11K | Q3 2026 |
| 2 | Jim Simons (1938–2024)Renaissance Technologies | 0.28% | $207.4M | 396.77K | ▲ Added 24% | +76.77K | Q3 2026 |
| 3 | Israel EnglanderMillennium Management | 0.16% | $232.7M | 468.41K | ▲ Added more than 10× | +437.59K | Q2 2026 |
| 4 | Ken GriffinCitadel Advisors | 0.15% | $253.5M | 510.43K | ▲ Added 50% | +171.14K | Q2 2026 |
| 5 | Baillie Gifford teamBaillie Gifford & Co | 0.13% | $139.1M | 266.06K | ▼ Reduced 2.4% | −6.51K | Q3 2026 |
Quarter by quarter
| Quarter | Filings in | Holders | Combined shares | Combined value | Bought | Sold |
|---|---|---|---|---|---|---|
| Q3 2026 | 92 | 3 | 688.84K | $360.1M | 1 | 2 |
| Q2 2026 | 157 | 5 | 1.61M | $800.5M | 3 | 2 |
| Q1 2026 | 157 | 3 | 661.5K | $295.4M | 1 | 3 |
| Q4 2025 | 157 | 4 | 771.38K | $349.7M | 2 | 3 |
| Q3 2025 | 157 | 4 | 1.01M | $394.6M | 2 | 2 |
| Q2 2025 | 157 | 4 | 1.28M | $569.3M | 1 | 4 |
| Q1 2025 | 156 | 5 | 1.68M | $814.8M | 1 | 4 |
| Q4 2024 | 156 | 4 | 1.61M | $649.6M | 1 | 4 |
A quarter's holder count is out of the filings in for that quarter — the newest quarter fills up over the 45 days investors have to file.
Each holder's shares
| Investor | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|---|---|
| Jim Simons (1938–2024) | 396.77K | 320.01K | 421.69K | 505.05K | 735.89K | 1M | 1.17M | 1.4M |
| Baillie Gifford team | 266.06K | 272.56K | 199.42K | 201.09K | 207.06K | 212.48K | 134.47K | 149.84K |
| Tweedy, Browne team | 26.01K | 40.12K | 40.39K | 39.15K | 39.07K | 37.25K | 38.32K | 40.63K |
| Ken Griffin | · | 510.43K | — | — | — | — | — | — |
| Israel Englander | · | 468.41K | — | — | — | — | 309.94K | — |
| Cathie Wood | — | — | — | 26.1K | 25.67K | 24.06K | 26.34K | 25.35K |
A dash: the investor filed for that quarter without this stock among their largest positions. A dot: no filing of theirs for that quarter is on file.
Questions and answers
Which superinvestors own VRTX?
In their latest 13F filings: Tweedy, Browne team (1.11% of the portfolio, $13.6M), Jim Simons (1938–2024) (0.28% of the portfolio, $207.4M), Israel Englander (0.16% of the portfolio, $232.7M), Ken Griffin (0.15% of the portfolio, $253.5M), Baillie Gifford team (0.13% of the portfolio, $139.1M).
Who bought VRTX last quarter?
Jim Simons (1938–2024) (added 24%), Israel Englander (added 1,420%), Ken Griffin (added 50%). “Last quarter” is each investor's latest reported quarter.
Who sold VRTX last quarter?
Reduced: Tweedy, Browne team (35% fewer shares), Baillie Gifford team (2.4% fewer shares).
How current is this?
It comes from Form 13F, which large managers file within 45 days of each quarter's end; the latest filing read here was made on Nov 16, 2026. Positions may have changed since, and a 13F shows long US-listed positions only.
Learn
Cite this page
Funkfolio, “Who owns Vertex Pharmaceuticals (VRTX)? Superinvestor holders”, data as of 16 November 2026. https://funkfolio.com/stock/VRTX/superinvestors
Underlying data: SEC EDGAR, Form 13F-HR filings of the investors tracked here.
Source: SEC EDGAR, Form 13F-HR filings of the 157 investors tracked here, matched to VRTX by security number and name. Only each investor's 150 largest positions per filing are read, so a small line in a very long portfolio is not seen, and a security held without a matched ticker cannot be found. “Last quarter” compares share counts with the investor's previous filing. Share counts are restated for a split only where a tracked investor held the stock through it. Filings appear up to 45 days after a quarter ends and show long US-listed positions only; this is not advice.